Google has released an AI called 'TxGemma' to help develop new therapeutic drugs. It can identify promising targets and predict the results of clinical trials, and it can also explain the reasons.

Gemini 2.5 Pro represents a significant step forward in AI model design, combining raw power with refined reasoning ...

Google is hoping to ease this process with its latest AI model, TxGemma. TxGemma is an open successor of Tx-LLM, which Google introduced last October to help with drug development. Tx-LLM garnered ...

This thinking capability was first introduced by Google in its Gemini 2.0 Flash Thinking Experimental AI model, which was ...

Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month.

To address these limitations, Google AI has introduced TxGemma, a collection of generalist large language models (LLMs) designed explicitly to facilitate various therapeutic tasks in drug development.

Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month.

Previous articleGoogle AI Released TxGemma: A Series of 2B, 9B, and 27B LLM for Multiple Therapeutic Tasks for Drug Development Fine-Tunable with Transformers ...